1014 Roche Dyno
BioCentury & Getty Images


Roche deal sets up capsid developer Dyno for faster growth, push into more therapeutic areas

Dyno is eligible for $1.8 billion in milestone payments 

Oct 14, 2020 | 8:50 PM GMT

Dyno’s latest and largest deal yet built around its AAV capsid platform will afford it further flexibility to

Read the full 530 word article

How to gain access

Continue reading with a
two-week free trial.